Fosaprepitant for the prevention of multiple-day cisplatin chemotherapy-induced nausea and vomiting: a prospective randomized controlled study
This trial was registered in the China Clinical Trials Registry on December 8, 2020 (chiCTR2000040675).
Authors
- Gaowa Jin (ORCID: https://orcid.org/0000-0002-7148-9195)
- Ying Jiang (ORCID: https://orcid.org/0000-0001-6381-1458)
- Xiaorong Li (ORCID: https://orcid.org/0000-0002-7295-655X)
- Quanfu Li
- Zewei Zhang (ORCID: https://orcid.org/0000-0003-0196-2132)
- Feng Chen (ORCID: https://orcid.org/0000-0002-9054-943X)
- Lu Wang (ORCID: https://orcid.org/0000-0002-0073-0666)
- Wenjuan Wang (ORCID: https://orcid.org/0000-0002-8833-2530)
- Jun Zhao (ORCID: https://orcid.org/0000-0002-0008-801X)
Institutions
- Inner Mongolia Medical University (CN)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1186/s40360-025-00964-6
- Primary Topic
- Nausea and vomiting management
- Type
- article
- Field-Weighted Citation Impact
- 0.00